Today it was reported that a Director at CareDx (NASDAQ: CDNA), Fred E. Cohen, exercised options to buy 15,000 CDNA shares at $1.22 a share, for a total transaction value of $18.3K.
Following this transaction Fred E. Cohen’s holding in the company was increased by 39.58% to a total of $1.15 million. In addition to Fred E. Cohen, 2 other CDNA executives reported Buy trades in the last month.
See today’s analyst top recommended stocks >>
Based on CareDx’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $17.82 million and GAAP net loss of $14.06 million. In comparison, last year the company earned revenue of $12.05 million and had a GAAP net loss of $3.97 million. The Company has a Price to Book ratio of 28.3311. Currently, CareDx has an average volume of 579.4K.
In the last 30 days, insiders have sold $343.1K worth of CDNA shares and purchased $18.3K worth of CDNA shares. The insider sentiment on CareDx has been negative according to 54 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CareDx, Inc. operates as a transplant diagnostics company, which offers pre- and post-transplant continuum. It focuses on discovery, development, and commercialization of diagnostic surveillance solutions.
